Drugs already being used to treat high blood pressure and cholesterol could reduce the risk of Alzheimer’s disease and dementia, according to a new Schaeffer Center study of nearly 700,000 Medicare beneficiaries.
Other featured articles
A Checklist to Help Prevent and Manage Pressure Injury
Schaeffer Fellow William Padula and colleagues developed a simple protocol to prevent and manage pressure injury referenced in Federal Appropriations Legislative Package.
Obesity, Second to Smoking as the Most Preventable Cause of US Deaths, Needs New Approaches
Nearly 40% of Americans are obese, and the numbers are climbing. The U.S. needs to get serious about solutions.
Conflicts of Interest in Dialysis: A Barrier to Policy Reforms
What are the possible benefits and risks of nephrologist’s financial participation in dialysis facility joint venture (JV) arrangements and financial participation in End‐stage Kidney Disease Seamless Care Organizations (ESCOs)? Eugene Lin and co-authors examine possible mechanisms for disclosure and reporting of such arrangements as well as risk mitigation.
Four Years Into MACRA: What Has Changed?
Changes to nephrology reimbursement present a unique opportunity to improve patient outcomes in a cost‐effective way. A multidisciplinary effort among policy makers, nephrology providers, and patient advocacy groups is critical to ensure these changes in care delivery safeguard and improve patient health.
About this section
Chronic diseases are among the most preventable and costliest conditions, consuming the overwhelming majority of Medicare resources. The Schaeffer Center assembles leading minds from across disciplines to address this challenge, striving to simplify labyrinthine systems of care and promote healthier outcomes.